Sfoglia per Autore
Inhibitory effect of conjugated linoleic acid on the growth of breast cancer cells
2004-01-01 Miglietta A; Bozzo F; Bocca C; Belotti S; Gabriel L; Canuto RA.
Modulation of MDA-MB-231 breast cancer cell proliferation and apoptosis by linoleic acid and conjugated linoleic acid
2004-01-01 Miglietta A; Bocca C; Bozzo F; Gabriel L; Canuto RA
Insulin can modulate MCF-7 cell response to paclitaxel
2004-01-01 MIGLIETTA A; PANNO ML; BOZZO F; L. GABRIEL; BOCCA C
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines
2004-01-01 MAGGIORA M; BOLOGNA M; CERU' MP; POSSATI L; ANGELUCCI A; CIMINI A; MIGLIETTA A; BOZZO F; MARGIOTTA C; MUZIO G; CANUTO R
Meccanismi alla base dell' effetto antiproliferativo e proapoptoticodell' acido linoleico coniugato in cellule di tumore mammario
2005-01-01 Bozzo F; Bocca C; Gabriel L; Canuto RA; Miglietta A.
Ruolo di PPARy e di proteine implicate nell’adesività cellulare nell’attivita’ antiproliferativa esercitata dal CLA in cellule di tumore mammario
2006-01-01 Bocca C; Bozzo F; Colombatto S; Miglietta A.
Coinvolgimento della via MAPK e di PPARg nell’effetto antiproliferativo dell’acido linoleico coniugato in cellule umane di carcinoma del colon
2006-01-01 Bozzo F; Bocca C; Miglietta A.
Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway
2006-01-01 A. MIGLIETTA; F. BOZZO; C. BOCCA; L. GABRIEL; A. TROMBETTA; S. BELOTTI; R.A. CANUTO
A Signal cross-talk between PPARgamma and E-cadherin/beta-catenin system modulates CLA response of human breast cancer cells
2007-01-01 Bocca C; Bozzo F; Miglietta A.
A Cla response of Human Breast cancer cells: mechanisms involved
2008-01-01 Bocca C; Bozzo F; Cannito S; Colombatto S; Miglietta A.
Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells
2008-01-01 Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A.
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells
2008-01-01 Cannito S; Novo E; Compagnone A; Valfrè di Bonzo L; Busletta C; Zamara E; Paternostro C; Povero D; Bandino A; Bozzo F; Cravanzola C; Bravoco V; Colombatto S; Parola M.
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth
2009-01-01 Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A.
CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways
2010-01-01 Bocca C; Bozzo F; Cannito S; Colombatto S; Miglietta A.
Antiproliferative effect of a novel nitro-oxy derivative of celecoxib in human colon cancer cells: role of COX-2 and nitric oxide.
2010-01-01 Bocca C; Bozzo F; Bassignana A; Miglietta A.
COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
2010-01-01 Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C.
Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
2011-01-01 C. Bocca; F. Bozzo; A. Bassignana; A. Miglietta
A NOVEL NITRO-OXY SUBSTITUTED ANALOGUE OF ROFECOXIB REDUCES HUMAN COLON CANCER CELL GROWTH
2012-01-01 Claudia BOCCA; Francesca BOZZO; Monica IEVOLELLA; Antonella MIGLIETTA
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells
2012-01-01 Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
COX2 inhibitor NS398 reduces HT-29 cell invasiveness by modulating signaling pathways mediated by EGFR and HIF1-α
2014-01-01 Bocca C; Bozzo F; Miglietta A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile